P11473 |
VDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P11473 |
VDR_HUMAN |
Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 |
VDR_HUMAN |
Hyper-parathyroidism [ICD-11: 5A51] |
P11473 |
VDR_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
P11473 |
VDR_HUMAN |
Mineral deficiency [ICD-11: 5B5K] |
P11473 |
VDR_HUMAN |
Psoriasis [ICD-11: EA90] |
P11473 |
VDR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 |
VDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P11473 |
VDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 |
VDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P11473 |
VDR_HUMAN |
Prostate disease [ICD-11: GA91] |
P11473 |
VDR_HUMAN |
Abnormal micturition [ICD-11: MF50] |
P11473 |
VDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 |
VDR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 |
VDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P10275 |
ANDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P10275 |
ANDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10275 |
ANDR_HUMAN |
Alcoholic liver disease [ICD-11: DB94] |
P10275 |
ANDR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 |
ANDR_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P10275 |
ANDR_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P10275 |
ANDR_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P10275 |
ANDR_HUMAN |
Hypo-osmolality/hyponatraemia [ICD-11: 5C72] |
P10275 |
ANDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P10275 |
ANDR_HUMAN |
Mammary tumour [ICD-11: 2C60-2C6Z] |
P10275 |
ANDR_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P10275 |
ANDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P10275 |
ANDR_HUMAN |
Testicular dysfunction [ICD-11: 5A81] |
P10275 |
ANDR_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
P10275 |
ANDR_HUMAN |
Alopecia [ICD-11: ED70] |
P10275 |
ANDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P10275 |
ANDR_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P10275 |
ANDR_HUMAN |
Contraceptive management [ICD-11: QA21] |
P10275 |
ANDR_HUMAN |
Heart failure [ICD-11: BD10-BD1Z] |
P10275 |
ANDR_HUMAN |
Muscle disorder [ICD-11: FB32-FB3Z] |
P10275 |
ANDR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P10275 |
ANDR_HUMAN |
Cystic fibrosis [ICD-11: CA25] |
P10275 |
ANDR_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P10275 |
ANDR_HUMAN |
Cachexia [ICD-11: MG20] |
P10275 |
ANDR_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P10275 |
ANDR_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P10275 |
ANDR_HUMAN |
Oesophagitis [ICD-11: DA24] |
P10275 |
ANDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10275 |
ANDR_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
P10275 |
ANDR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 |
ANDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P10275 |
ANDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P10275 |
ANDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Liver cancer [ICD-11: 2C12] |
O75874 |
IDHC_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P08183 |
MDR1_HUMAN |
Lung cancer [ICD-11: 2C25] |
P08183 |
MDR1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08183 |
MDR1_HUMAN |
Bacterial infection [ICD-11: 1A00-1C4Z] |
P08183 |
MDR1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P08183 |
MDR1_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
P08183 |
MDR1_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P37840 |
SYUA_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P37840 |
SYUA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P37840 |
SYUA_HUMAN |
Autonomic nervous system disorder [ICD-11: 8D87] |
P04150 |
GCR_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P04150 |
GCR_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P04150 |
GCR_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P04150 |
GCR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P04150 |
GCR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P04150 |
GCR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P04150 |
GCR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P04150 |
GCR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04150 |
GCR_HUMAN |
Adaptive immunity immunodeficiency [ICD-11: 4A01] |
P04150 |
GCR_HUMAN |
Adrenogenital disorder [ICD-11: 5A71] |
P04150 |
GCR_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P04150 |
GCR_HUMAN |
Asthma [ICD-11: CA23] |
P04150 |
GCR_HUMAN |
Atopic eczema [ICD-11: EA80] |
P04150 |
GCR_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P04150 |
GCR_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
P04150 |
GCR_HUMAN |
Eczema [ICD-11: EA80-EA89] |
P04150 |
GCR_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P04150 |
GCR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P04150 |
GCR_HUMAN |
Oesophagitis [ICD-11: DA24] |
P04150 |
GCR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P04150 |
GCR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P04150 |
GCR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04150 |
GCR_HUMAN |
Spine/trunk injury [ICD-11: ND51] |
P04150 |
GCR_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P04150 |
GCR_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
P04150 |
GCR_HUMAN |
Otitis externa [ICD-11: AA00-AA13] |
P04150 |
GCR_HUMAN |
Substance abuse [ICD-11: 6C40] |
P04150 |
GCR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P04150 |
GCR_HUMAN |
Depression [ICD-11: 6A70-6A7Z] |
P04150 |
GCR_HUMAN |
Mood disorder [ICD-11: 6A60-6E23] |
P04150 |
GCR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P04150 |
GCR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
P04150 |
GCR_HUMAN |
Retinopathy [ICD-11: 9B71] |
P04150 |
GCR_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q03181 |
PPARD_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q03181 |
PPARD_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q03181 |
PPARD_HUMAN |
Autoimmune liver disease [ICD-11: DB96] |
Q03181 |
PPARD_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q03181 |
PPARD_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
Q03181 |
PPARD_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q03181 |
PPARD_HUMAN |
Dyslipidemia [ICD-11: 5C80-5C81] |
Q03181 |
PPARD_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
Q03181 |
PPARD_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
Q03181 |
PPARD_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P09884 |
DPOLA_HUMAN |
Virus infection [ICD-11: 1A24-1D9Z] |
P51449 |
RORG_HUMAN |
Autoimmune disease [ICD-11: 4A40-4A45] |
P51449 |
RORG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P51449 |
RORG_HUMAN |
Psoriasis [ICD-11: EA90] |
P51449 |
RORG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P51449 |
RORG_HUMAN |
Crohn disease [ICD-11: DD70] |
P51449 |
RORG_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P51449 |
RORG_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P51449 |
RORG_HUMAN |
Liver cancer [ICD-11: 2C12] |
P51449 |
RORG_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P11388 |
TOP2A_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P11388 |
TOP2A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11388 |
TOP2A_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P11388 |
TOP2A_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
Q16850 |
CP51A_HUMAN |
Infectious meningitis [ICD-11: 1D01] |
Q16850 |
CP51A_HUMAN |
Nail/perionychium infection [ICD-11: EE12] |
Q16850 |
CP51A_HUMAN |
Onchocerciasis [ICD-11: 1F6A] |
Q9Y6A2 |
CP46A_HUMAN |
Acidosis [ICD-11: 5C73] |
Q9Y6A2 |
CP46A_HUMAN |
Epilepsy/seizure [ICD-11: 8A61-8A6Z] |
Q9Y6A2 |
CP46A_HUMAN |
Epileptic encephalopathy [ICD-11: 8A62] |
Q9Y6A2 |
CP46A_HUMAN |
Phakomatoses/hamartoneoplastic syndrome [ICD-11: LD2D] |
Q9Y6A2 |
CP46A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |